TheraRadar
← Back
Data updated: Jul 17, 2026

IMP

Pharma
Pharmaceuticals

IMP is a pharmaceutical company with 1 FDA-approved products.

1987
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

IMP's Key Drugs

IMP's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

IMP's Recent FDA Approvals

New NDA/BLA approvals for IMP over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

IMP's Therapeutic Areas

Disease areas where IMP has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

IMP Pipeline Snapshot

Active clinical trials for IMP across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling